Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Targeting hair follicles can improve skin treatments and reduce side effects.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Both mouse and rat models are effective for testing alopecia areata treatments.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.